We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

16 hedge funds and large institutions have $1.23M invested in Sonoma Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

14% more funds holding

Funds holding: 14 → 16 (+2)

9% more capital invested

Capital invested by funds: $1.13M → $1.23M (+$99K)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$45.1K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$21K
3
UBS Group
UBS Group
Switzerland
+$17.3K
4
Morgan Stanley
Morgan Stanley
New York
+$4.51K
5
AG
Advisor Group
Arizona
+$3.75K

Top Sellers

Rank Fund Capital Flow
1
BRWA
B. Riley Wealth Advisors
Florida
-$75K
2
Wells Fargo
Wells Fargo
California
-$4.51K
3
BA
Bard Associates
Illinois
-$3.75K
4
MFS
MSI Financial Services
Massachusetts
-$751
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
1
Bard Associates
Illinois
$501K -$3.75K -5 -0.8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$468K +$21K +28 +5%
BIT
3
BlackRock Institutional Trust
California
$111K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$58K – – –
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$47K +$45.1K +60 New
UBS Group
6
UBS Group
Switzerland
$18K +$17.3K +23 New
Morgan Stanley
7
Morgan Stanley
New York
$6K +$4.51K +6 +300%
Wells Fargo
8
Wells Fargo
California
$4K -$4.51K -6 -50%
BFA
9
BlackRock Fund Advisors
California
$4K +$751 +1 +20%
AG
10
Advisor Group
Arizona
$4K +$3.75K +5 New
Bank of Montreal
11
Bank of Montreal
Ontario, Canada
$2K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$2K +$751 +1 +100%
WAM
13
Wealthspire Advisors (Maryland)
Maryland
$1K – – –
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$1K +$751 +1 New
BRWA
15
B. Riley Wealth Advisors
Florida
– -$75K -103 Closed
MFS
16
MSI Financial Services
Massachusetts
– -$751 -1 Closed

SNOA Hedge Fund Activity: Q3 2016 in Review

16 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2016, worth a combined $1.23M — up 8.8% from $1.13M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SNOA positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $45.1K. The largest seller was B. Riley Wealth Advisors, exiting entirely with an estimated $75K sold.

  • 16 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2016, up from 14 in Q2 2016.
  • Funds reported $1.23M of Sonoma Pharmaceuticals stock for Q3 2016, up 8.8% quarter-over-quarter.
  • 4 funds opened new Sonoma Pharmaceuticals positions in Q3 2016 and 2 closed out, a net change of +2 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q3 2016 was Susquehanna International Group, an estimated $45.1K added.
  • The largest Sonoma Pharmaceuticals seller in Q3 2016 was B. Riley Wealth Advisors, an estimated $75K sold.

Based on aggregated 13F filings for Q3 2016.